Page last updated: 2024-11-04

sulpiride and Facial Pain

sulpiride has been researched along with Facial Pain in 1 studies

Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.

Facial Pain: Pain in the facial region including orofacial pain and craniofacial pain. Associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. Conditions which feature recurrent or persistent facial pain as the primary manifestation of disease are referred to as FACIAL PAIN SYNDROMES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Haghparast, A2
Yousefpour, M1
Rashvand, M1
Ghahari, L1
Rohani, B1

Other Studies

1 other study available for sulpiride and Facial Pain

ArticleYear
Involvement of dopaminergic system in the dentate gyrus of the hippocampus in modulating the orofacial pain-related behaviors in the rats.
    Behavioural pharmacology, 2023, 02-01, Volume: 34, Issue:1

    Topics: Analgesics; Animals; Carbachol; Dentate Gyrus; Dopamine; Facial Pain; Hippocampus; Humans; Male; Rat

2023